Interview with Piero Di Lorenzo. Anti-Covid vaccine in November, then the stock market listing: these are Mr. Vaccine’s goals.
Source: Il Riformista
After the announcement made by the EMA, the finishing line of getting a coronavirus vaccine is now closer for IRBM, the Italian company based in Pomezia (Rome). The vaccine candidate developed in collaboration with the University of Oxford and produced by the multinational AstraZeneca «is the first in western world to be considered by a regulatory agency» says the President of IRBM, Piero Di Lorenzo. The goal is close but in the meantime «you should get vaccinated against influenza to train your immune system» recommends Di Lorenzo.
Article by Maria Rosa Tomasello published on La Stampa – 02/10/2020